The DASH Study: A phase 1b study of dalantercept plus sorafenib in advanced hepatocellular carcinoma Meeting Abstract


Authors: Abou-Alfa, G. K.; Miksad, R. A.; Gutierrez, M.; Tejani, M. A.; Sharma, M.; Sun, W. J.; Henderson, C. A.; Baron, A. D.; Olowokure, O. O.; Pearsall, R. S.; Wilson, D.; Korth, C.; Sherman, M. L.; Pandya, S. S.
Abstract Title: The DASH Study: A phase 1b study of dalantercept plus sorafenib in advanced hepatocellular carcinoma
Meeting Title: 2015 Gastrointestinal Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 33
Issue: 3 Suppl.
Meeting Dates: 2015 Jan 15-17
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2015-01-20
Language: English
ACCESSION: WOS:000356883800493
PROVIDER: wos
DOI: 10.1200/JCO.2015.33.3_suppl.tps495
Notes: Meeting Abstract: TPS495 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ghassan Abou-Alfa
    568 Abou-Alfa